药明生物 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Jpmorgan Chase & Co. | 27 | 98,558,999 |
Li Ge | 4 | -50,563,500 |
Zhao Ning | 2 | -56,630,000 |
The Capital Group Companies, Inc. | 2 | -56,978,032 |
New Wuxi Life Science Holdings Limited | 1 | -56,000,000 |
New Wuxi Life Science Limited | 1 | -56,000,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 4,237,017 | 0 | 4,237,017 |
最近3个月 | 94,901,858 | 46,955,867 | 47,945,991 |
最近6个月 | 114,374,594 | 46,955,867 | 67,418,727 |
最近12个月 | 124,324,816 | 56,297,001 | 68,027,815 |
最近18个月 | 164,724,840 | 463,698,580 | -298,973,740 |
最近36个月 | 174,086,047 | 464,495,580 | -290,409,533 |
药明生物 内部交易
药明生物 最新内部交易
Li Ge | 2201 Interest of corporation controlled by you | 2024-03-28 | 买入 | 831,000 | 590,257,633 |
HK$13.88
|
-7.06%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-27 | 买入 | 3,406,017 | 213,733,454 |
HK$13.68
|
-5.70%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-27 | - | 335,176 | 73,508,032 |
HK$0
|
--
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-19 | 卖出 | 18,993,879 | 249,045,875 |
HK$14
|
-7.86%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-15 | 买入 | 21,989,717 | 267,094,253 |
HK$14.72
|
-12.36%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-08 | 卖出 | 9,356,187 | 251,840,412 |
HK$17.55
|
-26.50%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-07 | 买入 | 6,574,561 | 261,196,599 |
HK$17.41
|
-25.90%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-06 | 卖出 | 11,851,005 | 254,622,038 |
HK$21.18
|
-39.09%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-04 | 买入 | 14,781,821 | 265,274,623 |
HK$20.59
|
-37.35%
|
Jpmorgan Chase & Co. | 2201 Interest of corporation controlled by you | 2024-03-01 | 卖出 | 6,754,796 | 250,492,802 |
HK$18.85
|
-31.56%
|